急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗术后无复流现象的治疗进展  

Treatment progress of no-reflow phenomenon after percutaneous coronary intervention in patients withacute ST-segment elevation myocardial infarction

作　　者：范文甜 许亚欣 刘艺珂 陈春红[1] FAN Wentian;XU Yaxin;LIU Yike;CHEN Chunhong(Affiliated Hospital of Hebei University,Baoding 071000,China)

机构地区：[1]河北大学附属医院,河北保定071000

出　　处：《医学研究与教育》2023年第3期38-45,共8页Medical Research and Education

摘　　要：急性ST段抬高型心肌梗死(acute ST-segment elevation myocardial infarction,STEMI)是世界范围内心血管疾病患者死亡的主要原因,及时开通相关动脉是最有效的治疗手段。通过经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)开通罪犯血管是急性STEMI的首选再灌注策略,然而,约半数患者PCI术后仍得不到充分的微循环灌注,出现无复流现象(no-reflow phenomenon,NRP),这与不良心血管事件的发生密切相关。现综述PCI术后NRP药物治疗和非药物治疗的研究进展。Acute ST-segment elevation myocardial infarction(STEMI)is the cause of death for patients with cardiovascular disease worldwide,for which timely and effective opening of infarct related vessels is the most important treatment.Early restoration of culprit vessel patency by primary percutaneous coronary intervention(PCI)represents the reperfusion strategy of choice for patients with STEMI.However,about half of the patients still cannot get sufficient blood perfusion to the distal coronary microvasculature after PCI,which is closely related to the occurrence of adverse cardiovascular events.This situation is called no-reflow phenomenon(NRP).This article reviews recent treating progress of drug therapy and non-drug therapy for NRP after PCI.

关 键 词：急性ST段抬高型心肌梗死 经皮冠状动脉介入治疗 无复流现象 治疗进展 

分 类 号：R54[医药卫生—心血管疾病]